TrialJournal of the American College of Cardiology2013

Efficacy and safety of a novel dual modulator of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase in patients with hypercholesterolemia: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.

Christie M Ballantyne et al.PubMed ↗Publisher ↗

No numbers read from the abstract.